Cargando…

Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling

[Image: see text] Proteochemometric modeling (PCM) is a computational approach that can be considered an extension of quantitative structure–activity relationship (QSAR) modeling, where a single model incorporates information for a family of targets and all the associated ligands instead of modeling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tresadern, Gary, Trabanco, Andres A., Pérez-Benito, Laura, Overington, John P., van Vlijmen, Herman W. T., van Westen, Gerard J. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2017
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755953/ https://www.ncbi.nlm.nih.gov/pubmed/29172488 http://dx.doi.org/10.1021/acs.jcim.7b00338

Ejemplares similares

Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization
por: Doornbos, Maarten L. J., et al.
Publicado: (2018)

Scaffold Hopping to Imidazo[1,2-a]pyrazin-8-one Positive Allosteric Modulators of Metabotropic Glutamate 2 Receptor
por: de Lucas, Ana I., et al.
Publicado: (2021)

Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets
por: van Westen, Gerard JP, et al.
Publicado: (2013)

Towards predictive resistance models for agrochemicals by combining chemical and protein similarity via proteochemometric modelling
por: van Westen, Gerard J. P., et al.
Publicado: (2014)

Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors
por: Llinas del Torrent, Claudia, et al.
Publicado: (2019)

Significantly Improved HIV Inhibitor Efficacy Prediction Employing Proteochemometric Models Generated From Antivirogram Data
por: van Westen, Gerard J. P., et al.
Publicado: (2013)

Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling
por: Burggraaff, Lindsey, et al.
Publicado: (2019)

Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor sets
por: van Westen, Gerard JP, et al.
Publicado: (2013)

Chemical, Target, and Bioactive Properties of Allosteric Modulation
por: van Westen, Gerard J. P., et al.
Publicado: (2014)

Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development
por: van Westen, Gerard J. P., et al.
Publicado: (2011)

Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease
por: Luessen, Deborah J., et al.
Publicado: (2022)

Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
por: Liauw, Brandon Wey-Hung, et al.
Publicado: (2022)

Proteochemometric modeling in a Bayesian framework
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2014)

Allosteric Molecular Switches in Metabotropic Glutamate Receptors
por: Orgován, Zoltán, et al.
Publicado: (2020)

Predicting the binding type of compounds on the 4 adenosine receptors using proteochemometric models
por: van den Hoven, Olaf, et al.
Publicado: (2010)

Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
por: Kampen, Stefanie, et al.
Publicado: (2022)

Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2015)

Proteochemometric Modeling Identifies Chemically Diverse Norepinephrine Transporter Inhibitors
por: Bongers, Brandon J., et al.
Publicado: (2023)

Predicting Binding Free Energies of PDE2 Inhibitors. The Difficulties of Protein Conformation
por: Pérez-Benito, Laura, et al.
Publicado: (2018)

Preferential binding of allosteric modulators to active and inactive conformational states of metabotropic glutamate receptors
por: Yanamala, Naveena, et al.
Publicado: (2008)

Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor
por: Gutzeit, Vanessa A, et al.
Publicado: (2019)

Tetrahydronaphthyridine and Dihydronaphthyridinone Ethers As Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 5 (mGlu(5))
por: Turlington, Mark, et al.
Publicado: (2014)

Applications of proteochemometrics - from species extrapolation to cell line sensitivity modelling
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2015)

Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs
por: Burggraaff, Lindsey, et al.
Publicado: (2020)

Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants
por: Harpsøe, Kasper, et al.
Publicado: (2015)

Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window
por: Mihov, Yoan, et al.
Publicado: (2016)

Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformations
por: Nasrallah, Chady, et al.
Publicado: (2021)

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2020)

Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2020)

Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
por: Hovelsø, N, et al.
Publicado: (2012)

Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease
por: Doria, JG, et al.
Publicado: (2013)

In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5
por: Beggiato, Sarah, et al.
Publicado: (2018)

Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand
por: Dalton, James A. R., et al.
Publicado: (2017)

Accuracy and Precision of Alchemical Relative Free Energy Predictions with and without Replica‐Exchange
por: Wan, Shunzhou, et al.
Publicado: (2019)

The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum
por: Boccella, Serena, et al.
Publicado: (2020)

Constitutive activity of metabotropic glutamate receptor 7
por: Kammermeier, Paul J
Publicado: (2015)

Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells
por: Volpi, Claudia, et al.
Publicado: (2016)

Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012)

Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Epping-Jordan, Mark P., et al.
Publicado: (2023)

Identification of Positive Allosteric Modulators VU0155094 (ML397) and VU0422288 (ML396) Reveals New Insights into the Biology of Metabotropic Glutamate Receptor 7
por: Jalan-Sakrikar, Nidhi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1f3q925ammnnm1d3mo3l11pt47